a synthetic, opioid-like, centrally acting analgesic
it is not chemically related to
opiates
-
believed to act on mu opioid receptors & inhibit reuptake of serotonin & NA in the pain pathways of the CNS which may play the more important part of its actions.
affinity for mu receptor is 1/10th that of codeine, & 1/6000th less than morphine
unlike
morphine, it does not cause histamine release.
unlike
non-steroidal anti-inflammatory drugs (NSAIDs), it has no effect on PG synthesis & thus no effect on GIT bleeding, renal impairment, bronchospasm or reduced platelet activity, but it does still have some anti-inflammatory effect via direct inhibition of the formation of prostanoids.
rapidly absorbed orally with 70-90% bioavailability & peak plasma level at 2hrs after 50mg capsule or 5hr after S-R capsules.
peak level after IM injection is 45min.
undergoes extensive hepatic metabolism & like codeine is metabolized by CYP2D6 which is deficient in 10% of Caucasians (thus codeine has no effect in these people as it does not get converted to morphine, while tramadol, being an active drug as well as its metabolite has little difference compared to those who are not deficient)
half lives are 5h & 9h for its active metabolite
although widely used in Europe since the late 1970's, it was introduced in Australia & NZ in 1998, with a rapid increase in its use.